Amica Mutual Insurance CO Biogen Inc. Transaction History

Amica Mutual Insurance CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $1.5 Million - $1.98 Million	-5,787 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$219.29 - $241.72 $271,919 - $299,732	-1,240 Reduced 17.65%	5,787 $1.35 Million
Q1 2018 May 11, 2018	SELL	$260.13 - $367.91 $390,975 - $552,968	-1,503 Reduced 17.62%	7,027 $1.92 Million
Q4 2017 Feb 12, 2018	SELL	$307.64 - $344.58 $862,622 - $966,202	-2,804 Reduced 24.74%	8,530 $2.72 Million
Q2 2017 Aug 11, 2017	BUY	N/A	11,334	11,334 $3.08 Million

1,036

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Amica Mutual Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Amica Mutual Insurance CO with notifications on news.